Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding
10.1128/jvi.74.21.10074-10080.2000 · doi-reference
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
10.1093/protein/gzw040 · doi-reference
Easy quantitative assessment of genome editing by sequence trace decomposition
10.1093/nar/gku936 · doi-reference
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms
10.1126/science.3646751 · doi-reference
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
10.1128/jvi.59.2.284-291.1986 · doi-reference
Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages
10.1128/jvi.06157-11 · doi-reference
Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41
10.1089/aid.1998.14.1271 · doi-reference
Broad neutralization coverage of HIV by multiple highly potent antibodies
10.1038/nature10373 · doi-reference
Novel compound inhibitors of HIV-1NL4-3 Vpu
10.3390/v14040817 · doi-reference
Integrin-associated protein (CD47) and its ligands
10.1016/s0962-8924(00)01906-1 · doi-reference
HIV-1 Vpu promotes phagocytosis of infected CD4+ T cells by macrophages through downregulation of CD47
10.1128/mbio.01920-21 · doi-reference
Envelope glycoprotein internalization protects human and simian immunodeficiency virus-infected cells from antibody-dependent cell-mediated cytotoxicity
10.1128/jvi.01911-15 · doi-reference
An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface
10.1083/jcb.132.5.795 · doi-reference
Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family
10.1006/viro.1997.8839 · doi-reference
CD4 mimetics sensitize HIV-1-infected cells to ADCC
10.1073/pnas.1506755112 · doi-reference
Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity
10.1128/jvi.03230-13 · doi-reference
Cryo-EM structures of prefusion SIV envelope trimer
10.1038/s41594-022-00852-1 · doi-reference
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus
10.1038/s41467-022-32783-2 · doi-reference
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
10.1038/nature01188 · doi-reference
Antibody neutralization and escape by HIV-1
10.1038/nature01470 · doi-reference
Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography
10.1128/jvi.05297-11 · doi-reference
Crystal structure of a soluble cleaved HIV-1 envelope trimer
10.1126/science.1245625 · doi-reference
Non-neutralizing antibodies directed against HIV and their functions
10.3389/fimmu.2017.01590 · doi-reference
Antibody-dependent cellular phagocytosis in antiviral immune responses
10.3389/fimmu.2019.00332 · doi-reference
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
10.1016/j.jim.2010.12.016 · doi-reference
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
10.1371/journal.ppat.1008764 · doi-reference
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
10.1038/ncomms15711 · doi-reference
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys
10.1016/j.cell.2013.09.061 · doi-reference
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
10.1126/science.aab3886 · doi-reference
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV
10.1038/s41591-018-0161-0 · doi-reference
Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis
10.1038/s41467-022-28250-7 · doi-reference
Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk
10.1172/jci126391 · doi-reference
Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology
10.1016/j.cell.2015.10.027 · doi-reference
BST-2/tetherin: a new component of the innate immune response to enveloped viruses
10.1016/j.tim.2010.06.010 · doi-reference
Retroviral retention activates a Syk-dependent HemITAM in human tetherin
10.1016/j.chom.2014.08.005 · doi-reference
Stimulation of NF-κB activity by the HIV restriction factor BST2
10.1128/jvi.02272-12 · doi-reference
Innate sensing of HIV-1 assembly by tetherin induces NFκB-dependent proinflammatory responses
10.1016/j.chom.2012.10.007 · doi-reference
Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo
10.4049/jimmunol.1400490 · doi-reference
Upregulation of BST-2 by type I interferons reduces the capacity of Vpu to protect HIV-1-infected cells from NK cell responses
10.1128/mbio.01113-19 · doi-reference
Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice
10.1186/1742-4690-10-128 · doi-reference
